No and the comparison is uneven
The Strengthening Phase: Weeks 58 By weeks 58 in the BPC-157 timeline, tissue strength and load tolerance begin returning
ASHP is not responsible for the accuracy of transpositions from the original context
This page shows the reconstitution maths for 5 mg and 10 mg vials so every row can be checked, sets out the amounts the published studies genuinely reported, explains why DSIPs very short half-life makes evening timing the recurring question it is, and is explicit about where the evidence runs out
Less frequently, some people might experience temporary fatigue, dizziness, or nausea
The slower absorption profile of subcutaneous delivery suits BPC-157's mechanism: as a tissue-signaling peptide, it benefits from sustained presence in circulation rather than rapid spikes